| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |